Lymphoma
Lymphoma
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
60
Clinical Trials
Lymphoma
Phase I/II
Accepting Patients
nct/study# NCT03033914 / MSK16-1536
Phase I/II Of Nivolumab And A(B)VD In The Front-Line Setting For High Risk Hodgkin Lymphoma
Learn More
Lymphoma
Phase II
Accepting Patients
nct/study# NCT03233347 / LY-1601
A Phase II Trial Of PET-Directed Therapy Using AVD (Doxorubicin, Vinblastine, And Dacarbazine) Plus Brentuximab Vedotin Induction Chemotherapy, With Or Without Brentuximab Vedotin Plus Nivolumab, Followed By Nivolumab Consolidation For Patients With Previously Untreated Non-Bulky Limited Stage Hodgkin Lymphoma
Learn More
Lymphoma
NA
Accepting Patients
nct/study# NCT03711604 / RP6530-1803
An Open Label, Compassionate Use Study Of Tenalisib (RP6530) In Patients Currently Receiving Treatment On Tenalisib Trials In Hematological Malignancies
Learn More
Lymphoma
NA
Accepting Patients
nct/study# NA / 2020-0342-RWD-COVID
Real World Observational Database For COVID-19 Treatment And Outcomes
Learn More
Lymphoma
NA
Accepting Patients
nct/study# NA / 2021-0512
Clinical Efficacy And Mechanisms Of Resistance To Polatuzumab Vedotin In Patients With Large B-Cell Lymphoma After CAR T-Cell Therapy
Learn More
Lymphoma
NA
Accepting Patients
nct/study# NA / PROCLIP
Prospective Multicenter International Observational Study For Determination Of A Cutaneous Lymphoma International Prognostic Index Model And Impact Of Major Therapies In Patients With Advanced Mycosis Fungoides And Sézary Syndrome Advanced Stage PROCLIPI Project By The Cutaneous Lymphoma International Consortium (CLIC) Collaborative Alliance
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.